Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial

Wasan, Harpreet, MD ; Meade, Angela M, Dr ; Adams, Richard, MD ; Wilson, Richard, MD ; Pugh, Cheryl, BSc ; Fisher, David, MSc ; Sydes, Benjamin ; Madi, Ayman, MD ; Sizer, Bruce, MB ; Lowdell, Charles, FRCP ; Middleton, Gary, MD ; Butler, Rachel, BSc ; Kaplan, Richard, Prof ; Maughan, Tim, Prof

The lancet oncology, 2014-05, Vol.15 (6), p.631-639 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível